MAX HEALTHCARE INS LTD
Latest filings
Next results: Fri, 30 Oct · Financial Results- Postal ballot approves employee share incentives, chairman pay and wider business scope · Board & Shareholder Meetings
- Max Healthcare schedules Q2 and H1 FY27 investor results call · Board & Shareholder Meetings
- Board to approve September quarter and half-year results · Results
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates a network of hospitals across India providing in-patient and out-patient services across multiple specialties including oncology, with FY26 network revenue of INR 10,538 crore (+16% YoY) and network EBITDA margin of 26.2%; the FY26 BRSR filing separately reports turnover of Rs 8,373 crore with healthcare services contributing 98.23% of revenue. Network occupancy ran above 75% with ARPOB at INR 77,900. Digital channels contributed 31% of revenue (INR 838 crore) and international patient revenue was INR 227 crore (+12% YoY), forming 9% of hospital revenue. The largest identifiable cost line is employee costs at 16.2% of revenue, with other opex at 35.6%, depreciation at 5.3% and capex at 17.7% of revenue. Capacity is being expanded: more than 20% additional brownfield beds are being commissioned in phases, a 500-bed Gurgaon greenfield is targeted for end-FY27 commissioning, a 700-bed Lucknow Shaheed Path greenfield has been board-approved at INR 1,400 crore, a 450-bed super-specialty hospital is planned in Pune, and the acquired 250-bed Kalinga Hospital Bhubaneswar marks entry into Eastern India.
Scorecard
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from MAX HEALTHCARE INS LTD's filed financials and exchange disclosures
What does MAX HEALTHCARE INS LTD do?
MAX HEALTHCARE INS LTD is a Healthcare Services company listed on NSE and BSE, trading under the symbol MAXHEALTH.
Is MAX HEALTHCARE INS LTD profitable?
Yes. Over the trailing twelve months MAX HEALTHCARE INS LTD reported a net profit of ₹1,457 Cr on revenue of ₹8,712 Cr.
Does MAX HEALTHCARE INS LTD pay a dividend?
Yes. The dividend yield is 0.18% at the current price. It paid out 10% of its profit as dividend in FY26.
Is MAX HEALTHCARE INS LTD debt-free?
No. It reported borrowings of ₹3,478 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹2,813 Cr after cash. Debt stands at 0.32× equity. That is higher than 70% of its 24 Hospital peers.
Is MAX HEALTHCARE INS LTD expensive compared with its peers?
On trailing P/E, MAX HEALTHCARE INS LTD ranks 24 of 30 in Hospital — cheaper than 21% of them, against an industry median of 42.0×. This is a position, not a valuation judgement.
How much does the MAX HEALTHCARE INS LTD share price move in a day?
On a typical session MAX HEALTHCARE INS LTD moves 0.96% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are MAX HEALTHCARE INS LTD's next results?
Financial Results on Fri, 30 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track MAX HEALTHCARE INS LTD's announcements?
Every NSE and BSE filing by MAX HEALTHCARE INS LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.